150 related articles for article (PubMed ID: 37715132)
21. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
[TBL] [Abstract][Full Text] [Related]
22. A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer.
Incesu RB; Morra S; Scheipner L; Barletta F; Baudo A; Garcia CC; Tappero S; Piccinelli ML; Tian Z; Saad F; Shariat SF; de Cobelli O; Terrone C; Chun FKH; Carmignani L; Briganti A; Ahyai S; Longo N; Tilki D; Graefen M; Karakiewicz PI
Jpn J Clin Oncol; 2024 May; 54(5):592-598. PubMed ID: 38369557
[TBL] [Abstract][Full Text] [Related]
23. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
25. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
[TBL] [Abstract][Full Text] [Related]
27. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience.
Ondrusova M; Waczulikova I; Lehotska V; Zeleny T; Ondrus D
Clin Genitourin Cancer; 2017 Dec; 15(6):e1015-e1019. PubMed ID: 28673797
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study.
Hentrich MU; Bower M; Daugaard G; Dieing A; Bickel M; Berretta M; Lesmeister F; Jurinovic V; Stoehr A; Heinzelbecker J; Krznaric I; Dieckmann KP; Necchi A; Maroto Rey P; Rockstroh JK; Brito M; Pfister D; Hoffmann C
Cancer; 2022 Jan; 128(2):260-268. PubMed ID: 34592009
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
30. Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study.
Oing C; Oechsle K; Necchi A; Loriot Y; De Giorgi U; Fléchon A; Daugaard G; Fedyanin M; Faré E; Bokemeyer C
Ann Oncol; 2017 Mar; 28(3):576-582. PubMed ID: 27993806
[TBL] [Abstract][Full Text] [Related]
31. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
32. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
[TBL] [Abstract][Full Text] [Related]
33. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
34. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
35. Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
Beyer J; Collette L; Sauvé N; Daugaard G; Feldman DR; Tandstad T; Tryakin A; Stahl O; Gonzalez-Billalabeitia E; De Giorgi U; Culine S; de Wit R; Hansen AR; Bebek M; Terbuch A; Albany C; Hentrich M; Gietema JA; Negaard H; Huddart RA; Lorch A; Cafferty FH; Heng DYC; Sweeney CJ; Winquist E; Chovanec M; Fankhauser C; Stark D; Grimison P; Necchi A; Tran B; Heidenreich A; Shamash J; Sternberg CN; Vaughn DJ; Duran I; Bokemeyer C; Patrikidou A; Cathomas R; Assele S; Gillessen S;
J Clin Oncol; 2021 May; 39(14):1553-1562. PubMed ID: 33729863
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of testicular seminoma in individuals in West China: a 10-year follow-up study.
Chen Z; Qiu S; Cao D; Guo J; Chen B; Huang Y; Lai L; Bao Y; Dong Q; Liu L; Wei Q
Cancer Manag Res; 2019; 11():7639-7645. PubMed ID: 31616180
[TBL] [Abstract][Full Text] [Related]
38. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
[TBL] [Abstract][Full Text] [Related]
39. Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.
Gariscsak PJ; Anson-Cartwright L; Atenafu EG; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Glicksman RM; Hamilton RJ
Eur Urol Open Sci; 2022 Jun; 40():46-53. PubMed ID: 35638085
[TBL] [Abstract][Full Text] [Related]
40. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
